… model19 will be used to monitor the trial. Based on historical data, the event rate (treatment-…
of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 …

… atypical hemolytic uremic syndrome (aHUS) are unavailable. Improved characterization of
biomarkers in patients with aHUS may inform treatment and monitoring for … a mixed model for …

… C5, is indicated for the treatment of atypical haemolytic uraemic syndrome (aHUS) in several
… meningitides infection in ravulizumab recipients; therefore, patients should be monitored for …

… electronic UO monitoring to … disease in our model included documentation of- Oliguria, and
hemodialysis, followed by sepsis, dehydration or volume depletion, cardiovascular disease, …

… - marketing surveillance. Clin Exp Nephrol. 2019;23(1):65- 75. … A US cost- minimization model
comparing ravulizumab … sus eculizumab for treating atypical hemolytic uremic syndrome: a …

… , assessed regulatory function, and performed structural modeling of each variant protein.
These … treatment after 1-2 years of transplant with close monitoring per our protocol (Table 3). …

… mild renal insufficiency, continuing treatment with eculizumab/ravulizumab. By this case
report, we meant to point out the need for careful monitoring of people after vaccination, as it …

… care systems are supporting off-treatment monitoring were also raised: “I think the problem is
that health systems are very used to monitoring patients who are on a treatment..… model are …

… model 19 will be used to monitor the trial. Based on historical data, the event rate (treatment-…
for the standard of care is 0.06, and we expect that withdrawal of the treatment would give a …

… from eculizumab and immunosuppressive therapy based on MMF. Hence, monitoring of
anti-… The above model is consistent with the case we reported here in whom MP infection was …